Let's hope that they are using this method:
"Monoclonal antibodies (mAbs) hold great promise for treating diseases ranging from cancer to infectious disease. Manufacture of mAbs is challenging, expensive, and time-consuming using mammalian systems. We describe detailed methods used by Kentucky BioProcessing (KBP), a subsidiary of British American Tobacco, for producing high quality mAbs in a Nicotiana benthamiana host. Using this process, mAbs that meet GMP standards can be produced in as little as 10 days."
https://www.sciencedirect.com/science/article/abs/pii/S0076687921001932
...but let's face it, they're probably using a time-consuming mammalian - sporadic inducing - system....
- Forums
- ASX - By Stock
- Ann: Presentation to highlight broader potential of Deoxymabs
Let's hope that they are using this method:"Monoclonal...
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.46M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 8854419 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 3165475 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 8854419 | 0.007 |
12 | 2554182 | 0.006 |
10 | 3819992 | 0.005 |
6 | 4299000 | 0.004 |
2 | 1829016 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 3165475 | 3 |
0.009 | 1560014 | 3 |
0.010 | 377500 | 4 |
0.011 | 1780000 | 4 |
0.012 | 372407 | 3 |
Last trade - 10.06am 04/06/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
Day chart unavailable